Pure Global

A Study of BL-B01D1+SI-B003 in the Treatment of Locally Advanced or Metastatic Urothelial Carcinoma and Other Solid Tumors - Trial NCT05965856

Access comprehensive clinical trial information for NCT05965856 through Pure Global AI's free database. This Phase 2 trial is sponsored by Sichuan Baili Pharmaceutical Co., Ltd. and is currently Not yet recruiting. The study focuses on Urothelial Carcinoma. Target enrollment is 40 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT05965856
Phase 2
Not yet recruiting
drug
Trial Details
ClinicalTrials.gov • NCT05965856
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
A Study of BL-B01D1+SI-B003 in the Treatment of Locally Advanced or Metastatic Urothelial Carcinoma and Other Solid Tumors
A Phase II Clinical Study to Evaluate the Efficacy and Safety of BL-B01D1 Combined With SI-B003 in the Treatment of Patients With Locally Advanced or Metastatic Urothelial Carcinoma and Other Solid Tumors

Study Focus

Urothelial Carcinoma

BL-B01D1

Interventional

drug

Sponsor & Location

Sichuan Baili Pharmaceutical Co., Ltd.

Shanghai, China

Timeline & Enrollment

Phase 2

Aug 01, 2023

Aug 01, 2025

40 participants

Primary Outcome

Objective response rate (ORR),Recommended Phase II Dose (RP2D)

Summary

Objective: To investigate the efficacy, safety and tolerability of BL-B01D1+SI-B003
 combination in patients with locally advanced or metastatic urothelial carcinoma and other
 solid tumors, and to further explore the optimal dose and mode of combination.

ICD-10 Classifications

Carcinoma in situ: Other and unspecified urinary organs
Malignant neoplasm of ureter
Malignant neoplasms of urinary tract
Malignant neoplasm: Overlapping lesion of urinary organs
Malignant neoplasm: Urethra

Data Source

ClinicalTrials.gov

NCT05965856

Non-Device Trial